Clinical Trial Update: Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

View source ↗

Summary

This completed clinical trial reports real-world outcomes of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Changhua Christian Hospital | Conditions: AMD | Status: COMPLETED